Cargando…

Characteristics of severe asthma patients on biologics: a real-life European registry study

BACKGROUND: The use of anti-interleukin-5 (IL5) for severe asthma is based on criteria from randomised controlled trials (RCTs), but in real-life patients might not fulfil the eligibility criteria but may benefit from biologics. We aimed to characterise patients starting anti-IL5(R) in Europe and ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Principe, Stefania, Richards, Levi B., Hashimoto, Simone, Kroes, Johannes Anthon, Van Bragt, Job J.M.H., Vijverberg, Susanne J., Sont, Jacob K., Scichilone, Nicola, Bieksiene, Kristina, Ten Brinke, Anneke, Csoma, Zsuzsanna, Dahlén, Barbro, Gemicioglu, Bilun, Grisle, Ineta, Kuna, Piotr, Lazic, Zorica, Mihaltan, Florin, Popović-Grle, Sanja, Škrgat, Sabina, Marcon, Alessandro, Caminati, Marco, Djukanovic, Ratko, Porsbjerg, Celeste, Maitland Van Der Zee, Anke-Hilse
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2023
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152256/ https://www.ncbi.nlm.nih.gov/pubmed/37143845 http://dx.doi.org/10.1183/23120541.00586-2022

Ejemplares similares

Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study
por: Frix, Anne-Noelle, et al.
Publicado: (2022)

SHARP: enabling generation of real-world evidence on a pan-European scale to improve the lives of individuals with severe asthma
por: van Bragt, Job J.M.H., et al.
Publicado: (2021)

COVID-19 vaccination acceptance, safety and side-effects in European patients with severe asthma
por: Bossios, Apostolos, et al.
Publicado: (2023)

The Influence of Smoking Status on Exhaled Breath Profiles in Asthma and COPD Patients
por: Principe, Stefania, et al.
Publicado: (2021)

Blueprint for harmonising unstandardised disease registries to allow federated data analysis: prepare for the future
por: Kroes, Johannes A., et al.
Publicado: (2022)

Treating severe asthma: Targeting the IL‐5 pathway
por: Principe, Stefania, et al.
Publicado: (2021)

Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis
por: Kroes, Johannes A., et al.
Publicado: (2023)

What bothers severe asthma patients most? A paired patient–clinician study across seven European countries
por: Ainsworth, Ben, et al.
Publicado: (2023)

Administration of benralizumab in a patient with severe asthma admitted to the intensive care unit with COVID-19 pneumonia: case report
por: Kroes, Johannes Anthon, et al.
Publicado: (2022)

The effect of the COVID-19 pandemic on severe asthma care in Europe: will care change for good?
por: Eger, Katrien, et al.
Publicado: (2022)

Exhaled Metabolite Patterns to Identify Recent Asthma Exacerbations
por: van Bragt, Job J. M. H., et al.
Publicado: (2021)

Advancing Understanding of Mechanisms of Severe Asthma and Drug Effects Using Transcriptomics
por: Djukanović, Ratko
Publicado: (2019)

Fractional exhaled nitric oxide (FeNo) in different asthma phenotypes
por: Gemicioglu, Bilun, et al.
Publicado: (2014)

Clinical response to benralizumab can be predicted by combining clinical outcomes at 3 months with baseline characteristics
por: Kroes, Johannes A., et al.
Publicado: (2023)

Coronavirus Disease 2019 in Patients with Asthma: Case Study from a Tertiary Center Regarding Their Phenotypes and Their Adherence to Asthma Treatment by Telemedicine
por: Çalışkaner Öztürk, Buket, et al.
Publicado: (2022)

Cumulative corticosteroid-sparing effect of anti-interleukin-5/5Ra in eosinophilic asthma
por: Kroes, Johannes A., et al.
Publicado: (2022)

Treatment adherence and anxiety levels of bronchiectasis patients in the COVID-19 pandemic
por: Borekci, Sermin, et al.
Publicado: (2023)

The Relationship between Pre-Pandemic Interferon Gamma Release Assay Test Results and COVID-19 Infection: Potential Prognostic Value of Indeterminate IFN-γ Release Assay Results
por: Borekci, Sermin, et al.
Publicado: (2021)

Persistence of oxidant and protease burden in the airways after smoking cessation
por: Louhelainen, Noora, et al.
Publicado: (2009)

Lung Topology Characteristics in patients with Chronic Obstructive Pulmonary Disease
por: Belchi, Francisco, et al.
Publicado: (2018)

Elevation of sputum matrix metalloproteinase-9 persists up to 6 months after smoking cessation: a research study
por: Louhelainen, Noora, et al.
Publicado: (2010)

Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics
por: Principe, Stefania, et al.
Publicado: (2019)

Identification of recent exacerbations in COPD patients by electronic nose
por: van Bragt, Job J.M.H., et al.
Publicado: (2020)

A feasibility trial of a digital mindfulness-based intervention to improve asthma-related quality of life for primary care patients with asthma
por: Ainsworth, Ben, et al.
Publicado: (2021)

Demographic, Clinical and Management Characteristics of Newly Diagnosed COPD Patients in Turkey: A Real-Life Study
por: Suerdem, Mecit, et al.
Publicado: (2020)

An easy-to-use nomogram for predicting in-hospital mortality risk in COVID-19: a retrospective cohort study in a university hospital
por: Acar, Hazal Cansu, et al.
Publicado: (2021)

Correction to: Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma
por: Kermani, Nazanin Zounemat, et al.
Publicado: (2021)

Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma
por: Kermani, Nazanin Zounemat, et al.
Publicado: (2021)

Anomalous asthma and chronic obstructive pulmonary disease Google Trends patterns during the COVID-19 pandemic
por: Sousa-Pinto, Bernardo, et al.
Publicado: (2020)

Definitions of non-response and response to biological therapy for severe asthma: a systematic review
por: Khaleva, Ekaterina, et al.
Publicado: (2023)

Country-based report: the safety of omalizumab treatment in pregnant patients with asthma
por: GEMİCİOĞLU, Bilun, et al.
Publicado: (2021)

Association between presence of Bacillus Calmette–Guerin vaccine scar and coronavirus disease 2019
por: Caliskaner Ozturk, Buket, et al.
Publicado: (2022)

Case report: Acute toxic myocardial damage caused by 5-fluorouracil—from enigma to success
por: Lasica, Ratko, et al.
Publicado: (2022)

The impact of SARS-COV2 pandemic on the management oF IPF patients: Our narrative experience
por: Benfante, Alida, et al.
Publicado: (2021)

Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism
por: Ozturk, Buket Caliskaner, et al.
Publicado: (2021)

Correction to: Investigation of perfusion defects by Q‑SPECT/CT in patients with mild‑to‑moderate course of COVID‑19 and low clinical probability for pulmonary embolism
por: Ozturk, Buket Caliskaner, et al.
Publicado: (2021)

Immunomodulatory regulator blockade in a viral exacerbation model of severe asthma
por: Nicholas, Ben, et al.
Publicado: (2022)

Analysis of cell‐specific peripheral blood biomarkers in severe allergic asthma identifies innate immune dysfunction
por: Nicholas, Ben, et al.
Publicado: (2022)

Squamous Metaplasia Is Increased in the Bronchial Epithelium of Smokers with Chronic Obstructive Pulmonary Disease
por: Rigden, Helen M., et al.
Publicado: (2016)

Involvement of the epidermal growth factor receptor in IL‐13–mediated corticosteroid‐resistant airway inflammation
por: Davies, Elizabeth R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rmjlki84bb6qoosuqkli5jg1nm